These results provided valuable insights into the relationship between S100A16 and immune infiltration and showed that S100A16 may promote the immune evasion of tumor cells in the RCC tumor microenvironment, providing a reference for future fundamental research. The gene discussed is S100A16; the disease is neoplasm.